D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Netflix
NFLX
|
+$427M |
| 2 |
NXP Semiconductors
NXPI
|
+$267M |
| 3 |
Medtronic
MDT
|
+$245M |
| 4 |
Gilead Sciences
GILD
|
+$244M |
| 5 |
Hewlett Packard
HPE
|
+$213M |
Top Sells
| 1 |
Amazon
AMZN
|
+$406M |
| 2 |
CVS Health
CVS
|
+$381M |
| 3 |
LNKD
LinkedIn Corporation
LNKD
|
+$323M |
| 4 |
Wells Fargo
WFC
|
+$307M |
| 5 |
VMW
VMware, Inc
VMW
|
+$268M |
Sector Composition
| 1 | Technology | 14.04% |
| 2 | Healthcare | 13.47% |
| 3 | Financials | 11.87% |
| 4 | Consumer Discretionary | 10.86% |
| 5 | Industrials | 10.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
Emergent Biosolutions
EBS
$445M
| $21.7M | 0.04% |
659,797
+126,148
| +24% | +$4.14M |
|
|
SYT
427
DELISTED
Syngenta Ag
SYT
| $21.6M | 0.04% |
273,539
+219,810
| +409% | +$17.4M |
|
|
RATE
428
DELISTED
Bankrate Inc
RATE
| $21.6M | 0.04% |
1,953,930
+308,208
| +19% | +$3.41M |
|
429
Ares Capital
ARCC
$15.8B
| $21.4M | 0.04% |
1,296,685
+355,235
| +38% | +$5.86M |
|
430
Novartis
NVS
$245B
| $21.2M | 0.04% |
324,448
+59,937
| +23% | +$3.91M |
|
431
Globalstar
GSAT
$4.27B
| $21.1M | 0.04% |
890,822
+156,518
| +21% | +$3.71M |
|
432
Verizon
VZ
$184B
| $21.1M | 0.04% |
395,406
+17,349
| +5% | +$926K |
|
|
SYNH
433
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $21.1M | 0.04% |
400,403
+32,545
| +9% | +$1.71M |
|
434
LiveRamp
RAMP
$1.77B
| $20.8M | 0.04% |
775,393
-177,876
| -19% | -$4.77M |
|
435
Corning
GLW
$63.4B
| $20.7M | 0.04% |
851,548
+800,099
| +1,555% | +$19.4M |
|
436
Assured Guaranty
AGO
$3.92B
| $20.6M | 0.04% |
545,344
+63,532
| +13% | +$2.4M |
|
|
QGENF
437
DELISTED
QIAGEN NV
QGENF
| $20.4M | 0.03% |
729,597
+390,877
| +115% | +$11M |
|
438
Goodyear
GT
$2.42B
| $20.4M | 0.03% |
660,396
-1,713,732
| -72% | -$52.9M |
|
439
Coherent
COHR
$16.1B
| $20.3M | 0.03% |
683,669
-108,877
| -14% | -$3.23M |
|
|
CSII
440
DELISTED
Cardiovascular Systems, Inc.
CSII
| $20.2M | 0.03% |
836,350
-139,133
| -14% | -$3.37M |
|
441
Zillow
ZG
$20.5B
| $20.1M | 0.03% |
552,510
+276,796
| +100% | +$10.1M |
|
442
SPX Corp
SPXC
$9.39B
| $20.1M | 0.03% |
847,690
+2,204
| +0.3% | +$52.3K |
|
|
DO
443
DELISTED
Diamond Offshore Drilling
DO
| $20.1M | 0.03% |
+1,135,689
| New | +$20.1M |
|
444
Edgewell Personal Care
EPC
$1.02B
| $20.1M | 0.03% |
274,924
-189,747
| -41% | -$13.8M |
|
445
Atmos Energy
ATO
$26.4B
| $20.1M | 0.03% |
270,408
+83,913
| +45% | +$6.22M |
|
|
AGN
446
DELISTED
Allergan plc
AGN
| $19.9M | 0.03% |
94,651
+15,717
| +20% | +$3.3M |
|
|
CS
447
DELISTED
Credit Suisse Group
CS
| $19.8M | 0.03% |
1,386,932
+1,189,471
| +602% | +$17M |
|
448
Booz Allen Hamilton
BAH
$12.7B
| $19.8M | 0.03% |
548,692
+344,545
| +169% | +$12.4M |
|
|
TLRD
449
DELISTED
Tailored Brands, Inc.
TLRD
| $19.8M | 0.03% |
773,705
+151,789
| +24% | +$3.88M |
|
450
Under Armour Class C
UA
$2.08B
| $19.7M | 0.03% |
784,201
-363,557
| -32% | -$9.15M |
|